The researchers compared current GLP-1 medication users with former users
Securing an oral or poster presentation at the prestigious ADA sessions highlights the medical community's interest in efsubaglutide alfa as a competitive, convenient weekly or monthly treatment alternative in a highly dynamic metabolic disease market
Accessed February 17, 2026
20, the firm surveyed more than 600 participants who are currently taking a GLP-1, considering the therapy or have taken it in the past but no longer do
While the variety of GLP-1 medications makes it easy for patients to choose which method works best for them, injections may be more effective for weight loss
Weight loss often improves erectile function by enhancing blood flow, hormone balance, and cardiovascular health